A novel decision model to predict the impact of weight management interventions: the Core Obesity Model

Lopes, S., Meincke, H. H., Lamotte, M., Olivieri, A.‐V. and Lean, M. E.J. (2021) A novel decision model to predict the impact of weight management interventions: the Core Obesity Model. Obesity Science and Practice, 7(3), pp. 269-280. (doi: 10.1002/osp4.495) (PMID:34123394) (PMCID:PMC8170577)

[img] Text
235216.pdf - Published Version
Available under License Creative Commons Attribution.



Aims: Models are needed to quantify the economic implications of obesity in relation to health outcomes and health-related quality of life. This report presents the structure of the Core Obesity Model (COM) and compare its predictions with the UK clinical practice data. Materials and methods: The COM is a Markov, closed-cohort model, which expands on earlier obesity models by including prediabetes as a risk factor for type 2 diabetes (T2D), and sleep apnea and cancer as health outcomes. Selected outcomes predicted by the COM were compared with observed event rates from the Clinical Practice Research Datalink-Hospital Episode Statistics (CPRD-HES) study. The importance of baseline prediabetes prevalence, a factor not taken into account in previous economic models of obesity, was tested in a scenario analysis using data from the 2011 Health Survey of England. Results: Cardiovascular (CV) event rates predicted by the COM were well matched with those in the CPRD-HES study (7.8–8.5 per 1000 patient-years across BMI groups) in both base case and scenario analyses (8.0–9.4 and 8.6–9.9, respectively). Rates of T2D were underpredicted in the base case (1.0–7.6 vs. 2.1–22.7) but increased to match those observed in CPRD-HES for some BMI groups when a prospectively collected prediabetes prevalence was used (2.7–13.1). Mortality rates in the CPRD-HES were consistently higher than the COM predictions, especially in higher BMI groups. Conclusions: The COM predicts the occurrence of CV events and T2D with a good degree of accuracy, particularly when prediabetes is included in the model, indicating the importance of considering this risk factor in economic models of obesity.

Item Type:Articles
Additional Information:The authors acknowledge the medical writing assistance of PharmaGenesis Oxford Central, which was funded by Novo Nordisk A/S.
Glasgow Author(s) Enlighten ID:Lean, Professor Michael
Authors: Lopes, S., Meincke, H. H., Lamotte, M., Olivieri, A.‐V., and Lean, M. E.J.
College/School:College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
Journal Name:Obesity Science and Practice
ISSN (Online):2055-2238
Published Online:17 February 2021
Copyright Holders:Copyright © 2021 The Authors
First Published:First published in Obesity Science and Practice 7(3): 269-280
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record